Breneman JC, et al. The Children's Oncology Group Radiation
Oncology Discipline: 15 Years of Contributions to the Treatment
of Childhood Cancer. International Journal of Radiation Oncology, Biology, Physics. 2018;101(4):860-874.
Forster N, et al. Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery. J Neurooncol. 2018;138(2):335-340.
Hess CB, et al. An Update From the Pediatric Proton Consortium Registry. Front Oncol. 2018;8:165.
Minniti G, et al. Stereotactic Radiosurgery for Resected Brain Metastases: New Evidence Supports a Practice Shift, but Questions Remain. Int J Radiat Oncol Biol Phys. 2018;100(3):535-538.
Ermoian RP, et al. 45 Gy is not sufficient radiotherapy dose
for Group III orbital embryonal rhabdomyosarcoma after less than
complete response to 12 weeks of ARST0331 chemotherapy: A report from
the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2017;64(9).
Freese C, et al. Radiation
and subsequent reirradiation outcomes in the treatment of diffuse
intrinsic pontine glioma and a systematic review of the reirradiation
literature. Pract Radiat Oncol. 2017;7(2):86-92.
Halasz LM, et al. Treatment of Gliomas: A Changing Landscape. Int J Radiat Oncol Biol Phys. 2017;98(2):255-258.
Walterhouse DO, et al. Reduction of cyclophosphamide dose for
patients with subset 2 low-risk rhabdomyosarcoma is associated with an
increased risk of recurrence: A report from the Soft Tissue Sarcoma
Committee of the Children's Oncology Group. Cancer. 2017;123(12):2368-2375.
Brahimaj B, et al. Iodine-125 seed migration within brain parenchyma after brachytherapy for brain metastasis: case report. J Neurosurg. 2016;125(5):1167-1170.
Kirkpatrick JP, et al. Brain Metastases From Melanoma: Therapy at the Crossroads. Int J Radiat Oncol Biol Phys. 2016;96(4):713-716.